Why this Peninsula drug maker's stock soared 40% higher today By: San Francisco Business Times via Business Journals June 01, 2020 at 17:52 PM EDT The company is asking the FDA to approve the same drug as a treatment for prostate cancer and for uterine fibroids. Read More >>
